Fibroblast growth factor receptor inhibitors in glioma: a narrative review of recent advances
Gliomas are devastating CNS malignancies characterized by extreme molecular heterogeneity and poor prognosis; the fibroblast growth factor receptor (FGFR) signaling axis, which drives proliferation, stemness, and metabolic adaptation, has thus emerged as a crucial therapeutic target. This review sys...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-01-01
|
| Col·lecció: | Frontiers in Pharmacology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1714696/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|